R. Komaki

发表

Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial

Joe Y. Chang, J. Ajani, S. Swisher, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIa non-small-cell lung cancer].

R. Livingston, G. Noël, J. Mazeron, 2001, Cancer Radiothérapie.

Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone.

R. Komaki, P. Kupelian, P. Allen, 1996, International journal of radiation oncology, biology, physics.

Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide.

R. Komaki, R. Livingston, W. Sause, 1999, The New England journal of medicine.

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.

W. Curran, R. Livingston, W. Sause, 1995, Journal of the National Cancer Institute.

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group.

W. Curran, P. Kolesar, R. Livingston, 2001, Chest.

Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06.

W. Curran, S. McDonald, R. Komaki, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC): identification of five groups with different survival.

W. Sause, J. Cox, R. Komaki, 2000, International journal of radiation oncology, biology, physics.

Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC).

A H Russell, R. Komaki, L. Gaspar, 1998, International journal of radiation oncology, biology, physics.

A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group.

S. Adak, R. Livingston, M. Perry, 2000, The New England journal of medicine.

Dose distribution in total skin electron beam irradiation using the six-field technique.

R. Komaki, M. Gillin, D. Grimm, 1986, International Journal of Radiation Oncology, Biology, Physics.

Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04.

D. Ettinger, W. Curran, P. Rubin, 1997, International journal of radiation oncology, biology, physics.

R. Livingston, W. Sause, A. Turrisi, 2000, Cancer.

The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies.

W. Sause, B. Movsas, J. Cox, 1999, International journal of radiation oncology, biology, physics.

Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12.

B. Movsas, H. Wagner, C. Scott, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-year M. D. Anderson cancer center experience.

P. Allen, M. Delclos, J. Kelly, 2000, International journal of radiation oncology, biology, physics.

Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions.

A. Garden, P. Allen, M. Delclos, 1996, Radiology.

Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer.

R. Komaki, L. Milas, K. Mason, 1996, International journal of radiation oncology, biology, physics.

The Influence of Gender, Race, and Marital Status on Survival in Lung Cancer Patients: Meta-analysis of Radiation Therapy Oncology Group (RTOG) Trials

W. Curran, J. Coyne, H. Choy, 2009 .

Nccn Clinical Practice Guidelines in Oncology™ Non-small Cell Lung Cancer Practice Guidelines in Oncology – V.2.2010 Non-small Cell Lung Cancer Nccn Non-small Cell Lung Cancer Panel Members Roswell Park Cancer Institute Memorial Sloan-kettering Cancer Center Continue Nccn Guidelines Panel Disclosure

M. Kris, G. Bepler, L. Chirieac, 2022 .

Non-small cell lung cancer.

M. Kris, G. Bepler, L. Chirieac, 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review.

L. Milas, P. Allen, R. Schea, 1999, International journal of radiation oncology, biology, physics.

Non-small Cell Lung Cancer

M. Kris, G. Bepler, L. Chirieac, 2013, International Manual of Oncology Practice.